MedPath
HSA Approval

POTASSIUM CITRATE MIXTURE BP

SIN06732P

POTASSIUM CITRATE MIXTURE BP

POTASSIUM CITRATE MIXTURE BP

December 19, 1991

ICM PHARMA PTE. LTD.

ICM PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantICM PHARMA PTE. LTD.
Licence HolderICM PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SOLUTION

ORAL

Manufacturer Information

ICM PHARMA PTE. LTD.

ICM PHARMA PTE. LTD.

Active Ingredients

CITRIC ACID

5% w/v

Citric acid

POTASSIUM CITRATE

30% w/v

Potassium citrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

POTASSIUM CITRATE MIXTURE BP - HSA Approval | MedPath